Fetal Cell-Based Noninvasive Prenatal Testing Advances With Three New Feasibility Studies | GenomeWeb

NEW YORK (GenomeWeb) – Prenatal testing appears to be at the brink of another round of major innovation, with three recent reports demonstrating the feasibility of isolating fetal cells noninvasively and analyzing their DNA for aberrations, a goal researchers had pursued for decades.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.